Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)
D Franchimont, M Ferrante, E Louis, et al.
Acta Gastro-Enterologica Belgica
|
August 30, 2024
SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection
A Hoyois, C Gulkilik, L Mekkaoui, et al.
Gut
|
April 9, 2008
Predicting relapse in Crohn's disease: a biopsychosocial model
A Bitton, P L Dobkin, M D Edwardes, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2004
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
N Franchimont, V Putzeys, J Collette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
R Maréchal, B Vos, M Polus, et al.
Acta Gastro-Enterologica Belgica
|
November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillance
S Laurent, D Franchimont, J P Coppens, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitis
R Panaccione, R N Fedorak, G Aumais, et al.
Acta Gastro-Enterologica Belgica
|
October 13, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure
A Cremer, A Mansour, T Lobaton, et al.
Genes and Immunity
|
June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
P L De Jager, D Franchimont, A Waliszewska, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)
D Franchimont, M Ferrante, E Louis, et al.
Acta Gastro-Enterologica Belgica
|
August 30, 2024
SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection
A Hoyois, C Gulkilik, L Mekkaoui, et al.
Gut
|
April 9, 2008
Predicting relapse in Crohn's disease: a biopsychosocial model
A Bitton, P L Dobkin, M D Edwardes, et al.
Alimentary Pharmacology & Therapeutics
|
September 9, 2004
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
N Franchimont, V Putzeys, J Collette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
R Maréchal, B Vos, M Polus, et al.
Acta Gastro-Enterologica Belgica
|
November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillance
S Laurent, D Franchimont, J P Coppens, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitis
R Panaccione, R N Fedorak, G Aumais, et al.
Acta Gastro-Enterologica Belgica
|
October 13, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure
A Cremer, A Mansour, T Lobaton, et al.
Genes and Immunity
|
June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
P L De Jager, D Franchimont, A Waliszewska, et al.
Page
of 5